216 related articles for article (PubMed ID: 7488620)
1. A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes.
Shahinian S; Silvius JR
Biochim Biophys Acta; 1995 Nov; 1239(2):157-67. PubMed ID: 7488620
[TBL] [Abstract][Full Text] [Related]
2. Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
Martin FJ; Papahadjopoulos D
J Biol Chem; 1982 Jan; 257(1):286-8. PubMed ID: 7053372
[TBL] [Abstract][Full Text] [Related]
3. High-yield coupling of antibody Fab' fragments to liposomes containing maleimide-functionalized lipids.
Shahinian S; Silvius JR
Methods Enzymol; 2004; 387():3-15. PubMed ID: 15172154
[No Abstract] [Full Text] [Related]
4. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
5. Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds.
Martin FJ; Hubbell WL; Papahadjopoulos D
Biochemistry; 1981 Jul; 20(14):4229-38. PubMed ID: 7284322
[TBL] [Abstract][Full Text] [Related]
6. Effect of covalent attachment of immunoglobulin fragments on liposomal integrity.
Bredehorst R; Ligler FS; Kusterbeck AW; Chang EL; Gaber BP; Vogel CW
Biochemistry; 1986 Sep; 25(19):5693-8. PubMed ID: 3778879
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
8. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
[TBL] [Abstract][Full Text] [Related]
10. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
[TBL] [Abstract][Full Text] [Related]
11. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
[TBL] [Abstract][Full Text] [Related]
12. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.
Maruyama K; Takahashi N; Tagawa T; Nagaike K; Iwatsuru M
FEBS Lett; 1997 Aug; 413(1):177-80. PubMed ID: 9287139
[TBL] [Abstract][Full Text] [Related]
13. High yield, site-specific coupling of N-terminally modified beta-lactamase to a proteolytically derived single-sulfhydryl murine Fab'.
Mikolajczyk SD; Meyer DL; Starling JJ; Law KL; Rose K; Dufour B; Offord RE
Bioconjug Chem; 1994; 5(6):636-46. PubMed ID: 7873667
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of anti-VCAM-1-Fab'-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxib.
Kang DI; Lee S; Lee JT; Sung BJ; Yoon JY; Kim JK; Chung J; Lim SJ
J Microencapsul; 2011; 28(3):220-7. PubMed ID: 21425947
[TBL] [Abstract][Full Text] [Related]
15. Production of a PEGylated Fab' of the anti-LINGO-1 Li33 antibody and assessment of its biochemical and functional properties in vitro and in a rat model of remyelination.
Pepinsky RB; Walus L; Shao Z; Ji B; Gu S; Sun Y; Wen D; Lee X; Wang Q; Garber E; Mi S
Bioconjug Chem; 2011 Feb; 22(2):200-10. PubMed ID: 21254764
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Characterization of Trastuzumab Fab-Conjugated Liposomes (Immunoliposomes).
Jin S; Li H; Xu Y
Methods Mol Biol; 2023; 2622():197-205. PubMed ID: 36781762
[TBL] [Abstract][Full Text] [Related]
17. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
[TBL] [Abstract][Full Text] [Related]
18. Preparation of Fab' from murine IgG2a for thiol reactive conjugation.
Fowers KD; Callahan J; Byron P; Kopecek JI
J Drug Target; 2001; 9(4):281-94. PubMed ID: 11697031
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
20. The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates.
Goldstein D; Nassar T; Lambert G; Kadouche J; Benita S
J Control Release; 2005 Nov; 108(2-3):418-32. PubMed ID: 16226821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
